All instruments
Cohance Lifesciences Limited
Formerly Suven Pharmaceuticals Limited
- Stock
- COHANCE
- NSE
- ₹433.55−3.44%
- Delayed close, 06 Nov
Details
- INE03QK01018
- Healthcare
- Pharmaceuticals
- Face value ₹1
- Market cap ₹16,588 Cr
Dividend per share by FY
Split-adjusted · latest FY 2022–23 · FY of the ex-date
| Financial year | Total dividend |
|---|---|
| FY 2020–21 | ₹1.00 |
| FY 2021–22 | ₹4.00 |
| FY 2022–23 | ₹8.00 |
TTM payout
None
No payout in 12 months
Yield
None
No payout in 12 months
52-wk closing range ₹279.90 – ₹704.95 · split-adjusted
Yield and payout totals recalculated 07 Nov 2026.
Recent payouts
· 8 on record since FY 2020–21| Ex-date | Type | Record date | Amount |
|---|---|---|---|
| 09 Sep 2022 | Interim | 12 Sep 2022 | ₹1.00 |
| 09 Sep 2022 | Special | 12 Sep 2022 | ₹5.00 |
| 13 May 2022 | Interim | 17 May 2022 | ₹1.00 |
| 13 May 2022 | Special | 17 May 2022 | ₹1.00 |
| 15 Feb 2022 | Special | 16 Feb 2022 | ₹2.00 |
Amounts marked * were restated for a later split or bonus so they compare with today’s shares. Switch to “as filed” to see what was actually declared at the time — that is the figure on an old broker statement.